Reserpine and Colchicine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Reserpine
Colchicine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
If you take colchicine (for gout or familial Mediterranean fever) along with reserpine (a blood pressure medicine), the reserpine can slow down how your body clears colchicine out. That means colchicine can build up to higher levels than intended, which raises the risk of side effects like severe diarrhea, muscle weakness, or more serious problems.
The good news is this is very manageable. Your care team can lower your colchicine dose or watch you more closely. Please don't stop either medicine on your own. Just let your pharmacist or doctor know you take both so they can tailor the plan for you.
Effect: Reserpine may increase colchicine exposure via inhibition of P-glycoprotein (P-gp)-mediated efflux/clearance. Colchicine is a P-gp substrate, so co-administration can raise colchicine serum concentrations and increase toxicity risk (potentially fatal).
Direction: Increased colchicine effect. Evidence: theoretical. Onset: unspecified. Severity: major.
- Contraindicated in renal or hepatic impairment.
- Normal organ function: consider colchicine dose reduction or interruption; monitor for toxicity.
- Gout flare: limit to one 0.6 mg dose, repeat no sooner than 3 days.
- FMF: max 0.6 mg/day (may give as 0.3 mg twice daily).
What happens
Increased colchicine concentrations and increased risk of toxicity
Interaction Deep Dive
The p-glycoprotein transporter system uses colchicine as a substrate. When colchicine is given together with reserpine, colchicine serum concentrations may rise substantially, potentially leading to serious pharmacodynamic outcomes, including death. Colchicine and reserpine should not be combined in patients who have renal or hepatic impairment. For patients whose renal and hepatic function is normal, watch for indications of colchicine toxicity. It may be appropriate to lower the colchicine dose or stop it altogether21. When colchicine and reserpine must be used together, the colchicine dose for a gout flare should be cut to a single 0.6-mg tablet as one dose, and the repeat dose should not be administered until at least 3 days later. For patients with familial Mediterranean fever who require concurrent colchicine and reserpine, the colchicine daily maximum should not exceed 0.6 mg (which may be administered as 0.3 mg twice daily)1.
Why it happens (mechanism)
Inhibition of p-glycoprotein-mediated colchicine metabolism by reserpine
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Here is how this is typically managed:
- If you have kidney or liver problems, this combination should be avoided, so make sure your team knows your full history.
- With normal kidney and liver function, your colchicine dose may be reduced or paused, and your team may monitor you more closely for toxicity.
- For a gout flare, the colchicine dose is usually limited, with any repeat dose delayed by at least 3 days.
- For familial Mediterranean fever, the daily colchicine dose is typically capped.
Tell your pharmacist or doctor if you notice diarrhea, vomiting, muscle weakness, or numbness.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Reserpine and Colchicine together?
Reserpine can raise colchicine levels and increase toxicity risk, so your care team may lower your colchicine dose and watch you closely; this combination should be avoided if you have kidney or liver impairment. Keep taking both as prescribed and report any new diarrhea, vomiting, or muscle weakness. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Reserpine and Colchicine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Reserpine and Colchicine interaction managed?
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Here is how this is typically managed: If you have kidney or liver problems, this combination should be avoided, so make sure your team knows your full history. With normal kidney and liver function, your colchicine dose may be reduced or paused, and your team may monitor you more closely for toxicity. For… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Reserpine or Colchicine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: COLCRYS(TM) oral tablets, colchicine oral tablets. Mutual Pharmaceutical Company, Philadelphia, PA, 2009. DailyMed
- US Food and Drug Administration: Information for Healthcare Professionals: New Safety Information for Colchicine (marketed as Colcrys). US Food and Drug Administration. Rockville, MD. 2009.
Keep reading about Reserpine
Keep reading about Colchicine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist